[How to manage EBV reactivation and EBV-PTLD, CMV and human herpesvirus 6 reactivation and infection after allogeneic stem cell transplantation: A report of the SFGM-TC (update)]

Bull Cancer. 2017 Dec;104(12S):S181-S187. doi: 10.1016/j.bulcan.2017.10.022. Epub 2017 Nov 21.
[Article in French]

Abstract

The French society of bone marrow transplantation and cell therapy (SFGM-TC) organizes annually workshops in the attempt to harmonize clinical practices between different francophone transplantation center. Here, we report our recommendations regarding the management of Epstein Barr virus reactivation and lymphoproliferative disorders, cytomegalovirus (CMV) and human herpes virus 6 (HHV6) after allogeneic stem cell transplantation.

Keywords: Allogeneic stem cell transplantation; Allogreffe de cellules souches hématopoïétiques; CMV; EBV; HHV-6.

Publication types

  • Practice Guideline
  • Review

MeSH terms

  • Cytomegalovirus / physiology*
  • Cytomegalovirus Infections* / diagnosis
  • Cytomegalovirus Infections* / therapy
  • Cytomegalovirus Infections* / virology
  • Epstein-Barr Virus Infections* / diagnosis
  • Epstein-Barr Virus Infections* / therapy
  • Epstein-Barr Virus Infections* / virology
  • France
  • Hematopoietic Stem Cell Transplantation*
  • Herpesvirus 4, Human / physiology*
  • Herpesvirus 6, Human / physiology*
  • Humans
  • Lymphoproliferative Disorders / drug therapy
  • Roseolovirus Infections* / diagnosis
  • Roseolovirus Infections* / therapy
  • Roseolovirus Infections* / virology
  • Societies, Medical
  • Transplantation, Homologous
  • Viral Load
  • Virus Activation*